The S&P/ASX 200 index, the most prominent index of stocks listed on the Australian Securities Exchange (ASX), lost over one fifth of its value between the end of February and the end of March 2020, owing to the economic impact of the global coronavirus (COVID-19) pandemic. It has since recovered, and surpassed its pre-corona level in April 2021. Despite fluctuations, it reached its highest value in January 2025 at 8532.3 during this period.The S&P/ASX 200 index is considered the benchmark index for the Australian share market and contains the 200 largest companies listed on the ASX.
Between January 2010 and May 2024, the total market capitalization of domestic companies listed on the Australian Securities Exchange (ASX) grew from 1.32 trillion Australian dollars to 2.67 trillion Australian dollars. While the overall trend was upward, the growth curve was far from linear. The two most notable periods of decline were from March to September 2011, and the crash of March 2020 caused by the global coronavirus (COVID-19) pandemic.
While there have been fluctuations, the overall volume of monthly trades on the Australian Securities Exchange (ASX) did not not trend in either direction between November 2020 and October 2021. While there were 39.8 million trades in November 2020, this value only fell slightly to 39.4 million trades in October 2021.The vast majority of these trades were for equities, with the next largest category being listed exchange traded options (ETOs).
The average value of daily trades on Australian equity markets jumped sharply in the first quarter of 2020, increasing from around 6.5 billion Australian dollars in the previous quarter to over 9.4 billion Australian dollars. While this spike was likely due to the economic impact of the coronavirus (COVID-19) pandemic, values did not return back to their trend value for the previous two years. While the quarterly average between Q1 2017 and Q4 2019 was around 6.4 billion U.S. dollars, the average between the first quarter of 2020 and the first quarter of 2024 was over eight billion Australian dollars. In general, between 80 and 85 percent of these the total values traded was on the Australian Securities Exchange (ASX), with the remainder being on the Chi-X Australia platform, which is operated by the Chicago Board Options Exchange (CBOE).
https://quaintel.com/privacy-policyhttps://quaintel.com/privacy-policy
ASX Ltd Company Profile, Opportunities, Challenges and Risk (SWOT, PESTLE and Value Chain); Corporate and ESG Strategies; Competitive Intelligence; Financial KPI’s; Operational KPI’s; Recent Trends: “ Read More
https://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
Firms in the Real Estate Investment Trusts industry manage publicly listed trusts, focusing largely on commercial property. These trusts typically trade as stapled securities listed on the ASX. Real Estate Investment Trusts (REITs) in the industry purchase and manage retail, office, industrial and other types of property. REITs generate rental income by leasing properties to businesses and investment income through developing or selling properties. Rental income generated by REITs is relatively stable, while investment income can fluctuate significantly every year. Despite volatile operating conditions in recent years, industry firms have benefited from growth in the number of businesses and low borrowing costs over the two years through 2021-22, enabling many industry REITs to expand their property portfolios. Nonetheless, aggressive cash rate hikes, particularly during 2022-23, impacted the industry's performance by increasing borrowing costs and constraining expansion efforts. Industry-wide revenue has been growing at an annualised 0.9% over the past five years and is expected to total $20.9 billion in 2024-25, when revenue will rise by an estimated 1.7%. The industry has faced volatile trading conditions in recent years, with the COVID-19 pandemic creating significant demand disruptions in key product segments, including retail and office property markets. Industry enterprises have inched downwards in recent years due to acquisition activity among some of the industry's larger firms. Nonetheless, several new REITs have been listed on the ASX over the past few years, supporting growth in industry establishments. REITs are set to benefit from rising demand for commercial property over the coming years. Economic conditions will stabilise, with demand for retail and office property poised to climb. Some industrial companies are set to reshore manufacturing activities or retain more inventory to ensure the reliability of supply chains. This trend will boost demand for industrial property. Rising demand across key property segments will enable REITs to implement rent increases, supporting revenue growth and industry profitability over the period. Overall, industry revenue is forecast to grow at an annualised 3.8% over the five years through 2029-30 to total $25.2 billion.
https://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
The Australia Data Center Cooling Market report segments the industry into By Cooling Technology (Air-based Cooling, Liquid-based Cooling), By Type (Hyperscale (Owned and Leased), Enterprise (On-premise), Colocation), By End-user Industry (IT and Telecom, Retail and Consumer Goods, Healthcare, Media and Entertainment, Federal and Institutional Agencies, Other End-user Industries).
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Bank Bill Swap Rate in Australia decreased to 3.70 percent on Thursday June 5 from 3.71 in the previous day. This dataset includes a chart with historical data for Australia Bank Bill Swap Rate.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Coal fell to 104.85 USD/T on June 6, 2025, down 0.14% from the previous day. Over the past month, Coal's price has risen 6.18%, but it is still 21.17% lower than a year ago, according to trading on a contract for difference (CFD) that tracks the benchmark market for this commodity. Coal - values, historical data, forecasts and news - updated on June of 2025.
Australia's copper mining industry is experiencing significant shifts, with Sandfire Resources Limited emerging as the leader among ASX-listed copper miners. With a market capitalization of around 5.35 billion Australian dollars in March 2025, Sandfire has taken the top spot following BHP's acquisition of former industry leader OZ Minerals in early 2023. Copper mining in Australia Australia has some of the largest reserves of copper in the world. The leading markets for copper exports from Australia can be found in Asia, with China being the largest Australian copper recipient by value. Since 2019, the production of copper from Australian mines has followed a downward trend, with production quantities only slightly increasing in 2023. Despite this, Australia could play an important role in meeting the rising global demand for this critical mineral. Australia's global mining presence Australia's significance in the global mining industry extends beyond copper. BHP Group Limited, a British-Australian mining giant, leads the metals and mining companies on the ASX with a market capitalization of over 206 billion Australian dollars. BHP's diverse portfolio, which includes coal, copper, and iron ore, contributed to its impressive revenue of around 55.7 billion U.S. dollars in fiscal year 2024. The mining industry's importance to Australia's economy is highlighted by its substantial value addition, exceeding 350 billion Australian dollars in fiscal year 2023, and its role as a major employer in the country.
https://www.ibisworld.com/about/termsofuse/https://www.ibisworld.com/about/termsofuse/
The industry’s operating backdrop has changed dramatically over the past few decades. Changing policy landscapes have seen state governments wind back their involvement in the industry, creating space for a variety of participants, including the local operations of US-based IDEXX Laboratories and ASX-listed pathology provider Australian Clinical Labs. Technological advancements and the consequences of ongoing globalisation and the rapid global spread of animal and zoonotic diseases have also transformed the industry’s operating environment. The COVID-19 pandemic has highlighted both the threat of global zoonotic diseases and the integral role that the industry plays in protecting Australia's animal health system. In April 2020, CSIRO's high-containment biosecurity facility, the Australian Animal Health Laboratory, was renamed the Australian Centre for Disease Preparedness (ACDP) to reflect the changing nature of emerging infectious diseases that affect both human and animal health. Continued demand for the industry's services has contributed to modest growth in revenue and profit. Industry revenue is expected to have grown at an annualised 2.3% over the five years through 2024-25, to $370.0 million. This trend includes an anticipated expansion of 1.5% in 2024-25, as focus heightens on animal health and biosecurity and the threat of emergency animal disease incursions, like high pathogenicity avian influenza. Revenue is forecast to grow at an annualised 2.0% over the five years through 2029-30, to $408.5 million. Increased demand from veterinary practitioners and consumers’ willingness to spend more on their pets' general health and wellbeing will benefit the industry. Additional government measures to improve Australia's biosecurity system and the adoption of a One Health model will stimulate further changes in the industry's operating landscape, as will a growing focus on zoonotic diseases in the wake of the global COVID-19 pandemic. The use of innovative technologies in the wider animal care sector will also influence the industry going forwards.
https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy
According to Cognitive Market Research, the global Polysomnography devices market size will be USD 315.6 million in 2025. It will expand at a compound annual growth rate (CAGR) of 5.00% from 2025 to 2033.
North America held the major market share for more than 40% of the global revenue with a market size of USD 126.24 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2025 to 2033.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 94.68 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 72.59 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2033.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 15.78 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2025 to 2033.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 6.31 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2033.
The clinics category is the fastest-growing segment of the polysomnography devices industry.
Market Dynamics of Polysomnography Devices Market
Key Drivers for Polysomnography Devices Market
Rising Incidence of Sleep Disorders to Boost Market Growth
The growing prevalence of sleep disorders, such as insomnia, restless legs syndrome, and sleep apnea, is a major factor propelling the market for polysomnography devices. More people are seeking medical evaluations and diagnoses as a result of growing knowledge of the vital factor sleep plays in general health. Additionally, the rise in sleep-related disorders is also caused by aging populations, increased stress levels, and the rising incidence of obesity. Furthermore, the market is expanding as a result of healthcare providers investing in cutting-edge polysomnography device technologies to guarantee precise diagnosis and efficient treatment, which accelerates market expansion. For instance, the Compumedics FDA has approved the Somfit device for sale in the United States. In one of the biggest sleep marketplaces in the world, this represents the Somfit technology platform reaching yet another important strategic milestone. As previously announced by ASX statements, Somfit has been commercialized in Australia, with $1.2 million in sales. After the initial successful validation and start of sales efforts for Somfit in the Australian market, Compumedics can now start its commercialization activities in the important USA market. (Source: https://www.compumedics.com.au/en/blog/somfit-receives-fda-clearance-to-market-in-the-usa/)
Growing Healthcare Awareness to Drive Market Growth
The market for polysomnography devices is being driven by rising healthcare awareness. Diagnostic methods to detect sleep disorders are becoming more and more necessary as people learn more about the significance of getting enough sleep and how it affects general health. Moreover, the prevalence of disorders, including sleep apnea and insomnia, has increased as a result of public health campaigns, educational programs, and easier access to information via digital platforms. Additionally, more polysomnography devices are being used as a result of healthcare practitioners being proactive in screening for sleep-related problems. Early diagnosis and treatment are encouraged by this increased awareness, which propels market expansion worldwide.
Restraint Factor for the Polysomnography devices Market
High Costs and Lack of Expertise Will Limit Market Growth
The market for polysomnography devices is being restricted by high prices and a lack of experience. For smaller healthcare facilities and providers in underdeveloped nations, investing in advanced polysomnography devices can be difficult because of its high cost and continuous maintenance requirements. Furthermore, a lack of qualified technicians and sleep specialists who can properly operate and analyze polysomnography data is another issue. In addition, this lack of experience results in less than-ideal use of the gadgets, which would decrease their market growth. Thus, these budgetary and skill-related limitations impede further market expansion.
Market Trends in Polysomnography devices Market
An Increase in Funding for Sleep-Related Treatment Facilities
One major...
Sydney-founded Lovisa’s dominance in Australia’s fashion jewelry market is evident. As of 2023, the brand owned around 175 stores nationwide, far outpacing its closest fashion jewelry competitor, Collette, by over 100 locations. Moreover, this figure only refers to Lovisa’s local retail network, with the brand having an extensive reach outside the local region. Lovisa: Australia’s fashion jewelry diamond Lovisa’s rapid global expansion saw the company add approximately 100 jewelry stores to its network in the year ending June 2024, bringing its total to around 900 stores across multiple continents. The company’s fast growth has been accompanied by strong financial performance, with Lovisa reporting revenue exceeding 698 million Australian dollars that same year, continuing the upward trend. This trend has solidified Lovisa's position as a key player in the Australian retail landscape, with the company maintaining its place among the top retail firms listed on the Australian Securities Exchange (ASX). Australia’s fine jewelry retail landscape While Lovisa leads in the fashion jewelry segment, Australia’s fine jewelry market is dominated by different players. Prouds, Michael Hill, and Pandora topped the fine jewelry category by store numbers in 2023. New South Wales stands out as a key market, home to the highest number of jewelry stores countrywide, including nearly 300 fine jewelry outlets. While fashion jewelry offers value for money, fine jewelry caters to Australian shoppers looking to make luxury purchases or those hoping to create unique, personalized pieces. Therefore, high- and middle-income earners tend to account for the majority of fine jewelry purchases due to the use of pricier materials such as precious metals and gemstones.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
The S&P/ASX 200 index, the most prominent index of stocks listed on the Australian Securities Exchange (ASX), lost over one fifth of its value between the end of February and the end of March 2020, owing to the economic impact of the global coronavirus (COVID-19) pandemic. It has since recovered, and surpassed its pre-corona level in April 2021. Despite fluctuations, it reached its highest value in January 2025 at 8532.3 during this period.The S&P/ASX 200 index is considered the benchmark index for the Australian share market and contains the 200 largest companies listed on the ASX.